Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6890a406da9240c0a16543be3043e210 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6890a406da9240c0a16543be3043e210 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6890a406da9240c0a16543be3043e2102021-11-24T05:00:07ZDetection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial10.1136/bmjopen-2021-0491092044-6055https://doaj.org/article/6890a406da9240c0a16543be3043e2102021-10-01T00:00:00Zhttps://bmjopen.bmj.com/content/11/10/e049109.fullhttps://doaj.org/toc/2044-6055Wouter B NagengastJ Marc C van DijkAndré P van BeekRob A VergeerMark R PostmaIris SchmidtAstrid GW Korsten-MeijerRobert A FeijenSchelto KruijffWilfred F A den DunnenJos M A KuijlenGerrit van den BergBMJ Publishing GrouparticleMedicineRENBMJ Open, Vol 11, Iss 10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R |
spellingShingle |
Medicine R Wouter B Nagengast J Marc C van Dijk André P van Beek Rob A Vergeer Mark R Postma Iris Schmidt Astrid GW Korsten-Meijer Robert A Feijen Schelto Kruijff Wilfred F A den Dunnen Jos M A Kuijlen Gerrit van den Berg Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial |
format |
article |
author |
Wouter B Nagengast J Marc C van Dijk André P van Beek Rob A Vergeer Mark R Postma Iris Schmidt Astrid GW Korsten-Meijer Robert A Feijen Schelto Kruijff Wilfred F A den Dunnen Jos M A Kuijlen Gerrit van den Berg |
author_facet |
Wouter B Nagengast J Marc C van Dijk André P van Beek Rob A Vergeer Mark R Postma Iris Schmidt Astrid GW Korsten-Meijer Robert A Feijen Schelto Kruijff Wilfred F A den Dunnen Jos M A Kuijlen Gerrit van den Berg |
author_sort |
Wouter B Nagengast |
title |
Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial |
title_short |
Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial |
title_full |
Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial |
title_fullStr |
Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial |
title_full_unstemmed |
Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial |
title_sort |
detection by fluorescence of pituitary neuroendocrine tumour (pitnet) tissue during endoscopic transsphenoidal surgery using bevacizumab-800cw (departure trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial |
publisher |
BMJ Publishing Group |
publishDate |
2021 |
url |
https://doaj.org/article/6890a406da9240c0a16543be3043e210 |
work_keys_str_mv |
AT wouterbnagengast detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial AT jmarccvandijk detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial AT andrepvanbeek detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial AT robavergeer detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial AT markrpostma detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial AT irisschmidt detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial AT astridgwkorstenmeijer detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial AT robertafeijen detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial AT scheltokruijff detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial AT wilfredfadendunnen detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial AT josmakuijlen detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial AT gerritvandenberg detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial |
_version_ |
1718415917175537664 |